BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 18365153)

  • 1. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
    Valent P; Lechner K
    Wien Klin Wochenschr; 2008; 120(5-6):136-51. PubMed ID: 18365153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
    Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
    Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune hemolytic anemia].
    Karasawa M
    Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune hemolytic anemia: diagnosis and management].
    Philippe P
    Presse Med; 2007 Dec; 36(12 Pt 3):1959-69. PubMed ID: 17481848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe IgA-mediated auto-immune haemolytic anaemia in a 48-yr-old woman.
    Bardill B; Mengis C; Tschopp M; Wuillemin WA
    Eur J Haematol; 2003 Jan; 70(1):60-3. PubMed ID: 12631260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune haemolytic anaemia.
    Argüello Marina M; López Rubio M; Castilla García L
    Med Clin (Barc); 2023 Jan; 160(1):30-38. PubMed ID: 36334945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment.
    Barros MM; Blajchman MA; Bordin JO
    Transfus Med Rev; 2010 Jul; 24(3):195-210. PubMed ID: 20656187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
    Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
    Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
    Loriamini M; Cserti-Gazdewich C; Branch DR
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Hemolysis: Diagnosis and Treatment Recommendations.
    Barcellini W
    Semin Hematol; 2015 Oct; 52(4):304-12. PubMed ID: 26404442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hemolytic anemia.
    Čermák J; Písačka M
    Vnitr Lek; 2018; 64(5):514-519. PubMed ID: 30193520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autoimmune hemolytic anemias.
    Zanella A; Barcellini W
    Haematologica; 2014 Oct; 99(10):1547-54. PubMed ID: 25271314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and management of acquired immune haemolytic anaemia excluding neoplasia. Adequacy with the current guidelines published in 2009].
    Lauda-Maillen M; Catroux M; Roy-Peaud F; Souchaud-Debouverie O; El Masmouhi B; Roblot P
    Rev Med Interne; 2017 Oct; 38(10):648-655. PubMed ID: 28687137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
    Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
    Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.
    Reynaud Q; Durieu I; Dutertre M; Ledochowski S; Durupt S; Michallet AS; Vital-Durand D; Lega JC
    Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
    Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
    Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of monospecific antisera in the diagnosis and prognosis of autoimmune haemolytic anaemias.
    Kemppinen E; Vuopio P; Sandström R; Wager O
    Ann Clin Res; 1981 Apr; 13(2):85-90. PubMed ID: 7235614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and classification of autoimmune hemolytic anemia.
    Bass GF; Tuscano ET; Tuscano JM
    Autoimmun Rev; 2014; 13(4-5):560-4. PubMed ID: 24418298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune hemolytic anemia].
    Gerber B; Schanz U; Stüssi G
    Ther Umsch; 2010 May; 67(5):229-36. PubMed ID: 20509119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current approaches for the treatment of autoimmune hemolytic anemia.
    Jaime-Pérez JC; Rodríguez-Martínez M; Gómez-de-León A; Tarín-Arzaga L; Gómez-Almaguer D
    Arch Immunol Ther Exp (Warsz); 2013 Oct; 61(5):385-95. PubMed ID: 23689532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.